An ingredient list is a ranking, not a recipe. In the United States and in Korea, ingredients are printed from most to least by amount, but the ordering rule switches off at 1%: everything used at or below 1%, plus fragrance and colorants, may be printed in any order. That single exception is why a list can reliably tell you what makes up the bulk of a product and cannot tell you the concentration of any active, because in most skincare formulas the marketed active sits inside that unordered tail. Concentrations live somewhere other than the ingredient list: in a United States Drug Facts panel, in a Korean functional-cosmetic filing, or nowhere the shopper can see.
This guide is assembled from regulatory texts and medical-organization guidance, cited inline. It is not a product test report, it names no products, and it is not medical advice. Where a number could not be traced to a published authority, the number is not stated.
Step 1: Read the order, then find the point where order stops meaning anything
The United States rule is short. Under 21 CFR 701.3, the label of a cosmetic "shall bear a declaration of the name of each ingredient in descending order of predominance." Paragraph (f) of the same section then permits a three-bucket alternative:
- Ingredients other than color additives present at more than 1%, in descending order of predominance
- Ingredients other than color additives present at not more than 1%, without respect to order of predominance
- Color additives, without respect to order of predominance
Korea's rule has the same shape. Under the Cosmetics Act and its Enforcement Rule, ingredients are listed starting with the one used in the largest amount, and, as the government's plain-language law portal summarizes the provision in Annex 4 of the Enforcement Rule of the Cosmetics Act, "ingredients used at 1 percent or less, fragrance, or colorants may be listed without regard to order."
So a single ingredient list is really three lists stacked together.
| Zone of the list | What the order means | What you can conclude |
|---|---|---|
| Above 1% | A true ranking by amount | Which ingredients form the base of the formula, in order |
| At or below 1% | Nothing. Position is the brand's choice | Only that the ingredient is present at 1% or less |
| Fragrance and colorants | Nothing. May be placed anywhere | Only that they are present |
Two practical consequences follow immediately. First, an ingredient printed twelfth is not necessarily present in a smaller amount than one printed eighth. Second, moving a marketing ingredient upward inside the sub-1% zone is a formatting decision, not a formulation change.
Step 2: Locate the 1% line before you judge any ingredient's position
Because the regulation does not print a divider, the boundary has to be inferred, and inference is not reading. The most defensible marker is an ingredient with a published legal ceiling, because the ceiling puts a hard number on that position in the list.
Korea publishes exactly such a table. The Regulation on Safety Standards for Cosmetics carries a list of ingredients whose use is restricted, with maximum use levels by product type. Salicylic acid is a documented case. Regulatory reporting on the Korean rules records the permitted levels as 0.5% in general cosmetics, 2% in body-cleansing products, and 3% in rinse-off products, with the ingredient and its salts not for use in products for children under 13. In a Korean general cosmetic, therefore, salicylic acid cannot be above 0.5%, and every ingredient printed after it is in the unordered zone.
What this technique gives you is a ceiling, not a value. If a restricted ingredient with a 0.5% cap appears eighth, then ingredients nine and onward are all at 1% or less. It does not follow that ingredient nine is at 0.4%, or 0.04%, or any other figure. No published rule permits reading a percentage out of a position.
Step 3: Check where the hero ingredient actually sits, then resist the obvious conclusion
Run the list against the front of the package. Most marketing puts one ingredient in the product name or the hero line. Find it in the list, and note whether it appears above or below your inferred 1% line.
Then apply the correction that most ingredient-list commentary skips: sitting low in the list does not mean the ingredient is decorative. Korea's own functional-cosmetics framework proves it. Under the Regulation on the Review of Functional Cosmetics, the Ministry of Food and Drug Safety maintains a table of ingredients and set contents for functional products that may skip the full efficacy dossier. The contents are fixed values, and several of them are far below 1%.
| Functional category (Korea) | Ingredient | Content set by the regulation |
|---|---|---|
| Skin whitening | Niacinamide | 2% to 5% |
| Skin whitening | Arbutin | 2% to 5% |
| Skin whitening | Ascorbyl glucoside | 2% |
| Skin whitening | Magnesium ascorbyl phosphate | 3% |
| Skin whitening | Ethyl ascorbyl ether | 1% to 2% |
| Skin whitening | Alpha-bisabolol | 0.5% |
| Wrinkle improvement | Retinol | 2,500 IU/g |
| Wrinkle improvement | Retinyl palmitate | 10,000 IU/g |
| Wrinkle improvement | Adenosine | 0.04% |
| Wrinkle improvement | Polyethoxylated retinamide | 0.05% to 0.2% |
Adenosine is the instructive line. At 0.04%, adenosine will always be printed deep inside the unordered tail of the list, and at that content it is the exact amount Korea's regulation ties to a wrinkle-improvement claim. Alpha-bisabolol at 0.5% is the same story. A shopper who treats "near the end of the list" as a synonym for "not enough" will misread both.
The reverse error is just as common. An ingredient can also be present at a token amount purely so it can appear on the front of the box, and the ingredient list will look identical in both cases. That symmetry is the honest bottom line of this step: position rules out a high concentration, and it never rules a meaningful one in or out.
Step 4: Ask which regulatory box the claim sits in, because that is where the number lives
The single most useful move is to stop interrogating the ingredient list and ask what kind of claim the product is making. Different claim types put the concentration in different places, and only one of them prints it on the package.
| Claim type | Where the concentration is | Visible to a shopper? |
|---|---|---|
| United States over-the-counter drug (sunscreen, acne) | Drug Facts panel, under "Active ingredient" | Yes, on the package |
| Korean functional cosmetic filed against a listed ingredient | Fixed by the regulation's table | Yes, by looking up the table |
| Korean functional cosmetic reviewed on its own data | In the dossier submitted to MFDS | No |
| Plain cosmetic with a marketing claim | Nowhere published | No |
In the United States the Drug Facts rule is explicit. 21 CFR 201.66 requires the heading "Active ingredient" or "Active ingredients," "followed by the established name of each active ingredient and the quantity of each active ingredient per dosage unit." That is why a United States sunscreen or acne treatment shows a percentage and a Korean or American moisturizer does not. The percentage is a drug labeling requirement, not a cosmetic one.
The over-the-counter acne monograph shows what a defined dose looks like. 21 CFR 333.310 permits salicylic acid at "0.5 to 2 percent," benzoyl peroxide at "2.5 to 10 percent," and sulfur at "3 to 10 percent." Those ranges are the studied window for that claim in that market. A cosmetic that lists salicylic acid without a Drug Facts panel is making no statement about where in, or below, that window it falls.
Korea's parallel is the functional-cosmetic system, and it comes with a restriction worth knowing. Regulatory reporting on the Korean salicylic acid rules notes that MFDS has held that in a general (non-functional) cosmetic, salicylic acid may serve only as a preservative and the ingredient itself cannot be promoted for exfoliation-type purposes. If a Korean product is built around a salicylic acid story, that story is either supported by a functional-cosmetic filing or it is outside what the ingredient is permitted to be sold on.
Step 5: Decode the fragrance block, including its allergen tail
Fragrance is the one place where the list is legally allowed to hide identities. 21 CFR 701.3 states that "fragrance or flavor may be listed as fragrance or flavor," and Korea's rule likewise allows a fragrance blend to be shown as 향료, with the important exception that MFDS-designated allergenic components must be named individually.
The naming trigger is a concentration threshold, and it differs by whether the product is rinsed off.
| Market | Product type | Threshold for naming an individual fragrance allergen |
|---|---|---|
| Korea (25 designated substances) | Rinse-off | Above 0.01% |
| Korea (25 designated substances) | Not rinsed off | Above 0.001% |
| European Union | Rinse-off | Above 0.01% |
| European Union | Leave-on | Above 0.001% |
Korea's requirement covers 25 designated substances and has applied to individual labeling since January 2020, per the Seoul Institute of Public Health and Environment. The European Union thresholds sit in Article 19(1)(g) and Annex III of Regulation 1223/2009, and Commission Regulation (EU) 2023/1545 extended the list of fragrance substances subject to that labeling. In the United States there is no equivalent requirement in force yet. The Modernization of Cosmetics Regulation Act directs FDA to require individual fragrance allergen disclosure, and legal analyses of the agency's rulemaking agenda report that the proposed rule has slipped well past its statutory deadline.
The practical reading is counterintuitive. A Korean or European product with a long tail of named fragrance components is not more heavily fragranced than one that prints only 향료 or "Fragrance." It may simply have crossed a disclosure threshold, or be sold into a market that requires disclosure. A short fragrance entry is an absence of information, not an absence of allergens.
Step 6: Read the end of the list as a bucket, not as a ranking
Three separate rules collect at the bottom of a list, and each one erases information.
- Colorants sit outside the ranking. Under 21 CFR 701.3(f), color additives may be declared without respect to order of predominance, and Korea's Annex 4 rule treats colorants the same way. Their position tells you nothing at all.
- Shaded products and assortments may pool their colorants. Paragraphs (g) and (o) of 21 CFR 701.3 allow a "may contain" style declaration for shaded products and permit the color additives of all products in an assortment to "be declared in a single composite list," whether or not they are common to all the products. The colorants printed on the box are therefore not necessarily all in the item in your hand.
- Some identities are permitted to be missing. 21 CFR 701.3 provides that where an ingredient has been accepted by FDA as exempt from public disclosure as a trade secret, "in lieu of label declaration of identity the phrase 'and other ingredients' may be used at the end of the ingredient declaration." A list ending in that phrase is, by design, incomplete.
Step 7: Test the front of the package against the list
This is the step that produces the most useful findings, because several common claims have no definition behind them.
| Claim on the front | What the ingredient list can confirm | What it cannot |
|---|---|---|
| "Hypoallergenic" | Nothing | FDA states there are no federal standards or definitions governing the term, and that companies are not required to submit substantiation to FDA |
| "Unscented" | Whether a fragrance entry appears | FDA notes that products labeled unscented may still contain fragrance ingredients added to mask a base odor |
| "Fragrance-free" | Whether a fragrance entry appears | Whether an ingredient with a fragrance function is listed under another name |
| "Contains [botanical extract]" | That the extract is present | Its amount, its strength, or the ratio it was made at |
| "[Active] formula" | That the active is present, and a ceiling if it is a restricted ingredient | The concentration, unless a Drug Facts panel or a functional-cosmetic table supplies it |
| A wrinkle or brightening claim in Korea | Whether a listed functional ingredient appears | Nothing about a claim reviewed on the company's own data rather than the table |
FDA's own labeling-claims material is the authority for the first two rows: the agency's pages on cosmetics labeling claims, "hypoallergenic" cosmetics and fragrances in cosmetics state that labeling must be truthful and not misleading, that FDA does not pre-approve cosmetic labeling, and that FDA maintains no list of approved claims.
There is one contradiction the list can genuinely catch on its own. If the front of the package is built on an ingredient that appears after a restricted ingredient with a low legal ceiling, the hero is at 1% or less, whatever the front implies about its prominence. That is a real finding, and it is close to the only percentage-shaped conclusion a list supports.
Step 8: Know the five things an ingredient list can never tell you
- A concentration. Not for any ingredient, above or below the 1% line.
- A pH. Nothing in either country's ingredient-declaration rule requires it, and pH changes how an acid behaves.
- A function. The rules require ingredient identity, not the role the ingredient plays. The same acid can be a treatment ingredient or a pH adjuster, and the list reads identically.
- A grade or strength. The naming system exists to identify ingredients uniformly. INCI names are assigned by the International Cosmetic Ingredient Nomenclature Committee, sponsored by the Personal Care Products Council, which describes them as uniform, systematic, internationally recognized names for identifying cosmetic ingredients. Identification is not specification: one INCI name can cover materials made at different strengths.
- Whether a studied dose was used. Published dose ranges exist for some claims, such as the acne monograph range above. The ingredient list never states which point in a range, if any, the formula hit.
What the list is genuinely good for
Used within its limits, the list still answers real shopping questions.
- What the product mostly is. The above-1% zone is a true ranking, so it tells you whether a product is water-based, oil-based, or built on a humectant, which is the honest way to compare a lotion with a gel.
- Whether a specific ingredient you avoid is present. This is what full ingredient declaration is for, and it works.
- Whether a restricted ingredient is capped. Korea's restricted-ingredient table converts a name into a maximum.
- Whether the claim has a number behind it anywhere. A Drug Facts panel or a functional-cosmetic listing means yes. Silence means the number is not public.
- How two formats in one line differ. Comparing the above-1% zones of a toner and a serum from the same range is more informative than comparing their marketing.
FAQ
Does the first ingredient being water mean a product is cheap or diluted?
No. Water is the solvent in most water-based skincare, so the descending-order rule under 21 CFR 701.3 will usually place it first. The rule reports amount, not value, and it says nothing about what the rest of the formula does.
Can I estimate a percentage from an ingredient's position in the list?
No. Above 1% you get a rank order with no values attached, and at or below 1% the position is not even a rank, because 21 CFR 701.3(f) and Korea's Annex 4 rule both allow those ingredients to be listed in any order.
Why do some Korean products list a long string of fragrance components?
Because Korea requires that designated allergenic fragrance components be named individually once they exceed a threshold: above 0.01% in rinse-off products and above 0.001% in products that are not rinsed off, applied to individual labeling since January 2020. A long allergen list reflects disclosure, not a heavier fragrance load.
Where can I find the actual concentration of an active?
On the package only if the product is a United States over-the-counter drug, where 21 CFR 201.66 requires the quantity of each active ingredient. For a Korean functional cosmetic filed against the ministry's ingredient table, the content is fixed by the regulation and can be looked up. Otherwise the number is not public.
If an ingredient is listed near the end, is it too little to matter?
Not necessarily. Korea's functional-cosmetics table sets adenosine at 0.04% and alpha-bisabolol at 0.5% for their respective claims, and both would print near the end of any list. A late position rules out a high concentration and proves nothing else. Where a specific concern or condition is involved, that question belongs with a dermatologist rather than with the label.